JP2014530631A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530631A5 JP2014530631A5 JP2014537601A JP2014537601A JP2014530631A5 JP 2014530631 A5 JP2014530631 A5 JP 2014530631A5 JP 2014537601 A JP2014537601 A JP 2014537601A JP 2014537601 A JP2014537601 A JP 2014537601A JP 2014530631 A5 JP2014530631 A5 JP 2014530631A5
- Authority
- JP
- Japan
- Prior art keywords
- sucrose solution
- arsine
- dihydroquercetin
- glycyrrhizin
- sid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RBFQJDQYXXHULB-UHFFFAOYSA-N Arsine Chemical compound [AsH3] RBFQJDQYXXHULB-UHFFFAOYSA-N 0.000 claims description 6
- CXQWRCVTCMQVQX-LSDHHAIUSA-N Taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 claims description 6
- LPLVUJXQOOQHMX-MYOOOWEVSA-N Glycyrrhizic acid Natural products O=C(O)[C@H]1[C@@H](O)[C@H](O)[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](C(=O)O)O2)[C@@H](O[C@@H]2C(C)(C)[C@H]3[C@@](C)([C@H]4C(=O)C=C5[C@](C)([C@]4(C)CC3)CC[C@]3(C)[C@H]5C[C@](C(=O)O)(C)CC3)CC2)O1 LPLVUJXQOOQHMX-MYOOOWEVSA-N 0.000 claims description 4
- 239000004378 Glycyrrhizin Substances 0.000 claims description 4
- OHLBTNZSOHMDGY-JNMXELLOSA-N Mukurozioside IIb Natural products O(C/C(=C\CC/C(=C\CC/C(=C\CO[C@H]1[C@H](O[C@@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@H](O)[C@@H](CO)O1)/C)/C)/C)[C@H]1[C@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@H](O)[C@@H](CO)O1 OHLBTNZSOHMDGY-JNMXELLOSA-N 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 4
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 4
- -1 dihydrochalcone glucoside Chemical class 0.000 claims description 3
- WRPAFPPCKSYACJ-ZBYJYCAASA-N (2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6R)-6-[[(3S,8R,9R,10S,11R,13R,14S,17R)-17-[(5R)-5-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydrox Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CCC(C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@@H]3[C@]2(C)CC1)C)C(C)(C)O)[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O WRPAFPPCKSYACJ-ZBYJYCAASA-N 0.000 claims description 2
- XJIPREFALCDWRQ-UYQGGQRHSA-N (2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6S)-3,4-dihydroxy-6-[(3R,6R)-2-hydroxy-6-[(3S,8S,9R,10R,11R,13R,14S,17R)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclop Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJIPREFALCDWRQ-UYQGGQRHSA-N 0.000 claims description 2
- RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2S,4S)-4-amino-2-hydroxy-2-(1H-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 claims description 2
- QZOALWMSYRBZSA-XSAMIUIESA-N Osladin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1C[C@@H]2C(=O)C[C@H]3[C@@H]4CCC([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)C1O[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@H](C)CC1)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O QZOALWMSYRBZSA-XSAMIUIESA-N 0.000 claims description 2
- 108010010165 curculin Proteins 0.000 claims description 2
- GLLUYNRFPAMGQR-PPNXFBDMSA-N glycyphyllin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GLLUYNRFPAMGQR-PPNXFBDMSA-N 0.000 claims description 2
- ALAGDBVXZZADSN-UHFFFAOYSA-N pentazine Chemical compound C1=NN=NN=N1 ALAGDBVXZZADSN-UHFFFAOYSA-N 0.000 claims description 2
- 150000003085 polypodoside A derivatives Polymers 0.000 claims description 2
- DMRIOWKDQLGGAP-FPYDNAILSA-N polypodoside B group Chemical group [C@@H]12CC[C@H]([C@H](C)[C@H]3CC[C@H](C)[C@@H](OC4OC(C)C(O)C(O)C4O)O3)[C@@]1(C)CC[C@H]1C2=CC(=O)[C@H]2C[C@H](CC[C@]12C)OC1OC(CO)C(O)C(O)C1O DMRIOWKDQLGGAP-FPYDNAILSA-N 0.000 claims description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 2
- 150000007949 saponins Chemical class 0.000 claims description 2
- 239000000892 thaumatin Substances 0.000 claims description 2
- 235000010436 thaumatin Nutrition 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 4
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 claims 4
- 239000005720 sucrose Substances 0.000 claims 4
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6R)-6-[[(3S,8S,9R,10R,11R,13R,14S,17R)-17-[(2R,5R)-5-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 claims 1
- GSTCPEBQYSOEHV-QNDFHXLGSA-N 1-[2,6-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GSTCPEBQYSOEHV-QNDFHXLGSA-N 0.000 claims 1
- 239000001183 FEMA 4495 Substances 0.000 claims 1
- 239000001689 FEMA 4674 Substances 0.000 claims 1
- CWBZAESOUBENAP-IKACCGSXSA-N Naringin dihydrochalcone Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](OC=2C=C(O)C(C(=O)CCC=3C=CC(O)=CC=3)=C(O)C=2)O[C@@H](CO)[C@H](O)[C@H]1O CWBZAESOUBENAP-IKACCGSXSA-N 0.000 claims 1
- 241001092459 Rubus Species 0.000 claims 1
- YWPVROCHNBYFTP-OSHKXICASA-N Rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 claims 1
- XSDXQNVJNSCZNC-UHFFFAOYSA-N [5,7-dihydroxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydrochromen-3-yl] acetate Chemical compound C1=CC(OC)=CC=C1C1C(OC(C)=O)C(=O)C2=C(O)C=C(O)C=C2O1 XSDXQNVJNSCZNC-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
Description
他の追加の甘味増強剤は、グリシフィリン、イソモグロシドＶ、モグロシドＩＶ、シアメノシドＩ、ネオモグロシド、ムクロジオシドＩＩｂ、（＋）−ヘルナンズルシン、４β−ヒドロキシヘルナンズルシン、バイユノシド、フロミソシドＩ、ブリオズルコシド、ブリオシド、ブリオノシド、アブルソシドＡ〜Ｅ、シクロカリオシドＡ、シクロカリオシドＩ、アルビジアサポニンＡ〜Ｅ、グリチルリチン、アラボグリチルリチン、ペリアンドリンＩ〜Ｖ、プテロカリオシドＡおよびＢ、オスラジン、ポリポドシドＡおよびＢ、テロスモシドＡ８〜１８、フィロズルシン、フアングキオシドＥ、ネオアスチルビン、モナチン、３−アセトキシ−５，７−ジヒドロキシ−４’−メトキシフラバノン、２Ｒ，３Ｒ−（＋）−３−アセトキシ−５，７，４’ −トリヒドロキシフラバノン、（２Ｒ，３Ｒ）−ジヒドロケルセチン３−Ｏ−アセテート、ジヒドロケルセチン３−Ｏ−アセテート４’−メチルエーテル、ブラゼイン、クルクリン、マビンリン、モネリン、ネオクリン、ペンタジン、タウマチン、またはそれらの組み合わせを含んでもよい。
Claims (3)
- 混合物が１．２５％以下のスクロース溶液に等甘味度な、より特に１％のスクロース溶液に等甘味度な濃度で添加された、請求項７に記載の消費可能な組成物。
- トリロバチン、ヘスペレチンジヒドロカルコングルコシド、ナリンギンジヒドロカルコン、モグロシドＶ、ルオハングオ抽出物、ルブソシド、ルブス抽出物、グリシフィリン、イソモグロシドＶ、モグロシドＩＶ、シアメノシドＩ、ネオモグロシド、ムクロジオシドＩＩｂ、（＋）−ヘルナンズルシン、４β-ヒドロキシヘルナンズルシン、バイユノシド、フロミソシドＩ、ブリオズルコシド、ブリオシド、ブリオノシド、アブルソシドＡ〜Ｅ、シクロカリオシドＡ、シクロカリオシドＩ、アルビジアサポニンＡ〜Ｅ、グリチルリチン、アラボグリチルリチン、ペリアンドリンＩ〜Ｖ、プテロカリオシドＡおよびＢ、オスラジン、ポリポドシドＡおよびＢ、テロスモシドＡ８〜１８、フィロズルシン、フアングキオシドＥ、ネオアスチルビン、モナチン、３−アセトキシ−５，７−ジヒドロキシ−４’−メトキシフラバノン、２Ｒ，３Ｒ−（＋）−３−アセトキシ−５，７，４’−トリヒドロキシフラバノン、（２Ｒ，３Ｒ）−ジヒドロケルセチン３−Ｏ−アセテート、ジヒドロケルセチン３−Ｏ−アセテート４’−メチルエーテル、ブラゼイン、クルクリン、マビンリン、モネリン、ネオクリン、ペンタジン、タウマチン、またはそれらの組み合わせからなる群から選択される１または２以上の化合物を含む、請求項５〜１１のいずれか一項に記載の消費可能な組成物。
- 混合物を、１．２５％以下のスクロース溶液に等甘味度であり、より特に１％スクロース溶液に等甘味度である濃度で添加する、請求項１４〜１６のいずれか一項に記載の方法。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161550495P | 2011-10-24 | 2011-10-24 | |
| US61/550,495 | 2011-10-24 | ||
| PCT/EP2012/071088 WO2013060746A1 (en) | 2011-10-24 | 2012-10-24 | Compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014530631A JP2014530631A (ja) | 2014-11-20 |
| JP2014530631A5 true JP2014530631A5 (ja) | 2015-12-17 |
| JP6353364B2 JP6353364B2 (ja) | 2018-07-04 |
Family
ID=47115891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014537601A Active JP6353364B2 (ja) | 2011-10-24 | 2012-10-24 | 組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20140370177A1 (ja) |
| EP (1) | EP2770843B1 (ja) |
| JP (1) | JP6353364B2 (ja) |
| CN (1) | CN104039166B (ja) |
| BR (1) | BR112014009376B1 (ja) |
| IN (1) | IN2014CN02970A (ja) |
| MX (1) | MX354411B (ja) |
| SG (1) | SG11201401335QA (ja) |
| WO (1) | WO2013060746A1 (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201418899D0 (en) | 2014-10-23 | 2014-12-10 | Univ Hull | System for radiopharmaceutical production |
| GB201418897D0 (en) | 2014-10-23 | 2014-12-10 | Univ Hull | Methods and apparatus for the analysis of compounds |
| GB201418893D0 (en) * | 2014-10-23 | 2014-12-10 | Univ Hull | Monolithic body |
| BR112017019290A2 (pt) * | 2015-03-10 | 2018-05-02 | Univ Groningen | métodos de modificação enzimática dos glicosídeos de esteviol, glicosídeos de esteviol modificados obtidos deste modo e a sua utilização como edulcorantes |
| ES2875100T3 (es) * | 2016-12-30 | 2021-11-08 | Red Bull Gmbh | Composiciones, en particular composiciones edulcorantes |
| MX2019007879A (es) * | 2016-12-30 | 2019-12-05 | Red Bull Gmbh | Composiciones edulcorantes. |
| EP3700352B1 (en) | 2017-10-23 | 2021-09-22 | Symrise AG | Aroma composition |
| US20200221722A1 (en) * | 2019-01-15 | 2020-07-16 | Kween Foods LLC | Granola butter product and process of making a granola butter product |
| JP2022547292A (ja) * | 2019-09-05 | 2022-11-11 | フイルメニツヒ ソシエテ アノニム | フラバノン誘導体及び甘味増強剤としてのフラバノン誘導体の使用 |
| CN114513968A (zh) * | 2019-12-23 | 2022-05-17 | 弗门尼舍有限公司 | 三萜葡萄糖醛酸苷及其作为风味改良剂的用途 |
| CA3179775A1 (en) | 2020-04-20 | 2021-10-28 | Givaudan Sa | Compositions |
| GB202007984D0 (en) | 2020-05-28 | 2020-07-15 | Givaudan Sa | Compositions |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8293305B2 (en) * | 2005-10-11 | 2012-10-23 | Purecircle Sdn Bhd | Process for manufacturing a sweetener and use thereof |
| KR101356914B1 (ko) * | 2006-04-20 | 2014-01-28 | 지보당 에스아 | 단맛 강화 방법 |
| MX2009004344A (es) * | 2006-10-24 | 2009-05-05 | Givaudan Sa | Productos de consumo. |
| US9101161B2 (en) * | 2006-11-02 | 2015-08-11 | The Coca-Cola Company | High-potency sweetener composition with phytoestrogen and compositions sweetened therewith |
| RU2519718C2 (ru) * | 2007-12-03 | 2014-06-20 | ДСМ АйПи АССЕТС Б.В. | Новые нутрицевтические композиции, содержащие экстракт stevia или компоненты экстракта stevia, и их применения |
| CN101220062A (zh) * | 2008-01-23 | 2008-07-16 | 石任兵 | 一种同时制备甜菊苷和莱鲍迪苷a的方法 |
| CN102573521B (zh) * | 2009-09-04 | 2014-04-09 | 红点生物公司 | 包括莱鲍迪苷a或d的甜度增强剂 |
-
2012
- 2012-10-24 BR BR112014009376-8A patent/BR112014009376B1/pt active IP Right Grant
- 2012-10-24 JP JP2014537601A patent/JP6353364B2/ja active Active
- 2012-10-24 EP EP12780165.2A patent/EP2770843B1/en active Active
- 2012-10-24 SG SG11201401335QA patent/SG11201401335QA/en unknown
- 2012-10-24 MX MX2014004694A patent/MX354411B/es active IP Right Grant
- 2012-10-24 CN CN201280052169.0A patent/CN104039166B/zh active Active
- 2012-10-24 WO PCT/EP2012/071088 patent/WO2013060746A1/en active Application Filing
- 2012-10-24 US US14/352,223 patent/US20140370177A1/en active Pending
- 2012-10-24 IN IN2970CHN2014 patent/IN2014CN02970A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530631A5 (ja) | ||
| AR097213A1 (es) | Composiciones edulcorantes | |
| NO20090141L (no) | Stabiliserte, farmasøytiske preparater som omfatter fesoterodin | |
| BR112014031068A2 (pt) | derivados piridinona e piridazinona | |
| CL2013001386A1 (es) | Conjunto de composiciones nutricionales para lactantes que comprende una primera composicion para lactantes de 0 a 4 semanas, una segunda composicion para lactantes de 4 a 8 semanas, y una tercera composicion para lactantes de 3 a 6 meses, cada una con distintas densidades caloricas; y su uso para reducir la obesidad, diabetes y enfermedades cardiovasculares posteriormente en la vida. | |
| AR064149A1 (es) | Sal fumarato de (alfa s , beta r)-6 bromo- alfa-[ 2(dimetilamino ) etil)-2- metoxi - alfa-1-naftalenil- beta- fenil-3- quinolinaetanol | |
| DE602007011302D1 (de) | Ligustilid zur behandlung von erkrankungen des zentralen nervensystems | |
| BR112014009376A2 (pt) | composições | |
| BR112013011882A2 (pt) | fórmula nutricional adaptada à idade com densidade calórica particularmente adaptada para bebês e crianças | |
| BR112013003216A2 (pt) | composições sintéticas de ácido biliar e métodos | |
| NO20075758L (no) | Polymorfer av 3-0-(3',3'-dimetylsuccinyl) betulin syre di-N-metyl-D-glukamin | |
| JP2015535241A5 (ja) | ||
| TR200900881A2 (tr) | Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler | |
| BR112014000917A2 (pt) | composições | |
| BR112012026373A2 (pt) | derivados de ditiinopiridazinodiona | |
| BR112013006489A2 (pt) | composto de pirazol amida e seu uso. | |
| Maraka et al. | Cost-effectiveness of dental surgery procedures: a call for strengthening the evidence: reply | |
| Chan | Juniors needed support over MMC/MTAS | |
| Smith et al. | A95 INDOOR AND OUTDOOR POLLUTANTS AND RESPIRATORY HEALTH: Acetaminophen Potentiates Respiratory Responses To Environmental Tobacco Smoke | |
| Hüseyin et al. | THE ATTITUDES OF MEDICAL STUDENTS TOWARD THE ELDERLY | |
| Råberg | Högskolan i Halmstads miljöarbete-syndliggörande för studenterna | |
| Tauseef et al. | TRPC6 Channel Mediated Calcium Entry Requires RhoA and Myosin Light Chain Kinase To Increase Lung Vascular Permeability. | |
| Hansen | College Student Oareer Story | |
| TR200707555U (tr) | Jet nebulizör. | |
| 赖桢 | Nostalgia in Michael Ondaatje's Running in the Family |